Economy

HC Wainwright Cuts Antares Pharma, Inc. (ATRS) Price Target to $3.50

An investor in NASDAQ:ATRS shares filed a lawsuit over alleged violations of Federal Securities Laws by Antares Pharma Inc. It now has negative earnings. The regular trading started at $1.94 but as the trading continued, the stock receded, settling the day with a fall of -5.29%. The stock decreased 0.52% or $0.98 on November 7, reaching $186.24.

Antares Pharma Cmn (NASDAQ:ATRS) as of recent trade, has shown weekly downbeat performance of -1.65% which was maintained at -52.27% in 1-month period. The stock exchanged hands with 1,628,771 numbers of shares compared to its average daily volume of 2.21M shares. Also, a 9.82% expansion in Antares Pharma, Inc. Antares Pharma has a 52 week low of $1.50 and a 52 week high of $4.09. Antares Pharma Cmn (NASDAQ:ATRS) has trailing twelve month Return on Assets of -25.7%, which is key indicator of how profitable a company is relative to its total assets. The firm earned "Buy" rating on Monday, August 7 by Jefferies. The rating was initiated by H.C. Wainwright on Friday, June 23 with "Buy". The stock closing price is now trading downward to its 50 day moving average with change of -36.48%, tumbled to its 20 day moving average with figure of -21.62% and behind its 200 day moving average with value -35.97%. The share price volatility of the stock remained at 7.09% for the month and by reducing the timeframe to just a week, the volatility stood at 7.67%. The mean rating score for this stock is at 2.50.

On October 20, 2017, Antares Pharma Inc announced receipt of a Complete Response Letter ("CRL") from the FDA regarding the NDA for Xyosted, "indicat [ing] that the FDA can not approve the NDA in its present form". After $-0.02 actual earnings per share reported by Antares Pharma Inc for the previous quarter, Wall Street now forecasts 50.00% negative EPS growth.

Several hedge funds have recently made changes to their positions in the company. 130,000 were reported by M&T Bancorporation. Benjamin F Edwards & Inc owns 6,000 shares. Prelude Mngmt Ltd accumulated 0.03% or 100,330 shares. Moreover, Gsa Capital Prtnrs Llp has 0.04% invested in Antares Pharma Inc (NASDAQ:ATRS). Schwab Charles Investment Management Inc. now owns 289,093 shares of the specialty pharmaceutical company's stock valued at $822,000 after acquiring an additional 26,847 shares during the last quarter. Prudential Fin holds 14,590 shares or 0% of its portfolio. California-based Fuller And Thaler Asset has invested 0.03% in Antares Pharma Inc (NASDAQ:ATRS). HC Wainwright reissued a "buy" rating and set a $5.00 target price on shares of Antares Pharma in a research report on Sunday, September 10th. Bnp Paribas Arbitrage Sa has 15,090 shares. However, the institutional investors are observed to own 37.20% of the total shares. In current trading day Editas Medicine, Inc. California State Teachers Retirement Sys, California-based fund reported 254,600 shares. After a recent check, it is observed that the insiders for the firm now own 1.30% shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Like this

Latest


09 November 2017
Do you want to stay at a full-sized Lego house?
Those who enter the competition are required to describe what they'd build if they had an infinite supply of Lego bricks. There is also a basement of iconic LEGO sets and the living room is complete with LEGO armchairs and a TV.

09 November 2017
Endo International plc (NASDAQ:ENDP) Quarterly Sales Review
The company provided EPS guidance of $3.35-3.65 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.52. Oppenheimer Holdings, Inc. reissued a "hold" rating on shares of Endo International PLC in a report on Tuesday, August 8th.

09 November 2017
Mduduzi Manana to learn his fate
Magistrate Ramsamy Reddy refused the media's application to cover sentencing but said journalists could reapply. Prosecutor Anne-Marie Smith gave the court documentary evidence of Manana's previous convictions.

09 November 2017
US Silica Holdings, Inc. (SLCA) Announces Quarterly Earnings Results
SunTrust Banks, Inc. reiterated a "buy" rating and set a $43.00 price objective (up previously from $35.00) on shares of U.S. This repurchase authorization authorizes the mining company to reacquire shares of its stock through open market purchases.

09 November 2017
Total to Buy Engie's Upstream LNG Portfolio for $1.49 Billion
Engie is to sell its upstream and midstream LNG business to compatriot Total, as it refocuses its energies on downstream gas. Engie will retain and expand its downstream LNG activities; regasification infrastructure and retail sales.

09 November 2017
BP plc (BP) Holdings Cut by Cullen Frost Bankers Inc
Brown Brothers Harriman Communications has 0.08% invested in Europa Oil & Gas (Holdings) Plc (LON:EOG) for 156,844 shares. Sandhill Prns Limited Liability has 2.98% invested in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 2.40 million shares.

09 November 2017
Cursive writing will be required in IL elementary schools after veto override
Unpaid bills are a key factor in the state's credit profile as they provides a picture of its cash and liquidity status. In October, Illinois sold $6 billion of general obligation bonds to help pay off the backlog.

09 November 2017
NKCAC offers heating bill subsidy
Pender County Department of Social Services is offering Low Income Energy Assistance Program (LIEAP) once again this year. Some of these households also received help to address no-heat crisis situations and fix broken heating systems.

09 November 2017
AFREXIMBANK sites industrial parks, world-class hospital in Nigeria
According to him, Nigeria remains a very important shareholder of Afreximbank and also the highest beneficiary of its funds. Most banks in Nigeria have lines of credit from us.

09 November 2017
Revenue Estimates Analysis Of Retail Properties of America, Inc. (RPAI)
Geode Capital Management Llc increased National Retail Properties (NNN) stake by 5.83% reported in 2017Q2 SEC filing. Seven analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock.



Recommended